US · Healthcare

Innoveren Scientific Inc. (IVRN)

Biotechnology

Innoveren Scientific Inc. (IVRN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IVRN

P/E ratio

25.00

Innoveren Scientific Inc. (IVRN) — FAQ

What is IVRN's P/E ratio?

The price-to-earnings (P/E) ratio for Innoveren Scientific Inc. (IVRN) is 25.00 (data as of 2026-05-23).

Does Innoveren Scientific Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Innoveren Scientific Inc. (IVRN). Check the MyAverix Finance app for the latest dividend data.

What sector is Innoveren Scientific Inc. in?

Innoveren Scientific Inc. (IVRN) is classified in the Healthcare sector (Biotechnology industry).

What exchange is IVRN listed on?

IVRN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)